Agios Pharmaceuticals’ cover photo
Agios Pharmaceuticals

Agios Pharmaceuticals

Pharmaceutical Manufacturing

Cambridge, MA 93,961 followers

Fueled by Connections to Transform Rare Diseases™

About us

Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment. Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect the priorities of rare disease communities. Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve. Review our social media guidelines: https://www.agios.com/community-guidelines/

Website
http://www.agios.com
Industry
Pharmaceutical Manufacturing
Company size
501-1,000 employees
Headquarters
Cambridge, MA
Type
Public Company
Founded
2008
Specialties
Biopharmaceuticals, Cellular Metabolism, and Rare Diseases

Locations

Employees at Agios Pharmaceuticals

Updates

Affiliated pages

Similar pages

Browse jobs

Funding

Agios Pharmaceuticals 7 total rounds

Last Round

Post IPO equity

US$ 256.0M

See more info on crunchbase